Delivery Order SPE2DB25D3018-SPE2DB25FUYDW
- Not listed
- The Defense Logistics Agency awarded a $2,654.77 delivery order to AmerisourceBergen Drug Corp on September 12, 2025, for the supply of Januvia 50 mg tablets (90-count units). This competitively awarded, firm fixed-price contract is scheduled for completion by September 15, 2025, with performance at the contractor's corporate office in Conshohocken, Pennsylvania. The award carries no set-aside designation and represents a child order under AmerisourceBergen's larger federal contract portfolio....
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 5, 2025, for the supply of Januvia 50 mg tablets (90-count units) valued at $3,274.38. This firm fixed-price delivery order, with an ultimate completion date of August 6, 2025, represents a continuation of the company's pharmaceutical supply relationship with DLA. The award carries no set-aside designation, indicating it was competitively awarded. AmerisourceBergen Drug Corp, headquartered in...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Januvia 50 mg tablets (90-count package) valued at $1,109.94 under a firm fixed-price contract. This delivery order, issued on August 22, 2025, represents a non-competitive, non-set-aside award with an ultimate completion date of August 25, 2025. The pharmaceutical product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters and primary operations....
- The Defense Logistics Agency awarded a delivery order valued at $1,273.37 to AmerisourceBergen Drug Corp for the supply of Januvia 100 mg tablets (90-count units) on September 9, 2025, with completion scheduled for September 10, 2025. This competitively awarded, firm fixed-price contract with no set-aside designation reflects a routine pharmaceutical procurement fulfilling military healthcare supply requirements. The work will be performed at AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of Januvia 100 mg tablets (90-count) under a firm fixed-price contract valued at $1,122.20. The award, which is effective through August 19, 2025, was issued as a non-set-aside competitive award and represents a child contract under AmerisourceBergen's larger pharmaceutical supply agreement. The product will be delivered to the company's corporate office location in...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 27, 2025, for the supply of Januvia 50 mg tablets (90-count packages) under a firm fixed-price contract with a ceiling value of $1,637.19. This non-set-aside award represents a competitive procurement for pharmaceutical products supporting federal medical supply requirements. The order is scheduled for ultimate completion by June 30, 2025, with performance taking place at AmerisourceBergen's corporate...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Januvia 50 mg tablets (90-count) valued at $1,122.26 under a firm fixed price contract. This delivery order, issued on August 27, 2025, with completion scheduled for August 28, 2025, represents a child contract under AmerisourceBergen's larger indefinite delivery vehicle with DLA. The award was made through competitive procurement with no set-aside designation, and the product will be delivered to the...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 12, 2025, for the supply of Januvia 100 mg tablets (90-count units) at a ceiling value of $1,091.46. This firm fixed-price delivery order, with an ultimate completion date of August 13, 2025, represents a competitively awarded contract with no set-aside designation. The product will be sourced from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 9, 2025, for the supply of Januvia 100 mg tablets (90-count packages) valued at $1,718.04. This is a firm fixed price, non-set-aside delivery order with an ultimate completion date of September 10, 2025, to be performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a single line item purchase under AmerisourceBergen's existing pharmaceutical supply relationship...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 15, 2025, for the supply of Januvia 100 mg tablets (90-count units) under a firm fixed-price contract with a ceiling value of $6,429.02. This non-set-aside delivery order is scheduled for completion by August 18, 2025, with performance at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a routine pharmaceutical procurement action supporting federal...
- SPE2DB25D3018Indefinite Delivery Contract
- SPE2DB25D3018-SPE2DB25FUYDWDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $7,891.24 on August 6, 2025, for the supply of Januvia 50 mg tablets (90-count packages). This is a firm fixed-price delivery order with an ultimate completion date of August 7, 2025, to be fulfilled at the contractor's facility in Conshohocken, Pennsylvania. The award utilized no set-aside designation and was competitively awarded through open competition. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. This prime pharmaceutical supply vehicle enables AmerisourceBergen to deliver a comprehensive range of medications, vaccines, and medical supplies to support military healthcare programs globally. As a major pharmaceutical distributor and critical federal medical procurement vendor, AmerisourceBergen serves the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems through this flexible contract framework designed to meet ongoing pharmaceutical supply needs across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $7.9k | 8/6/25 |